Joseph Y. Chang - 13 Sep 2021 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Role
EVP, Chief Scientific Officer
Signature
/s/ Gregory Belliston as Attorney-in-Fact for Joseph Y. Chang
Issuer symbol
NUS
Transactions as of
13 Sep 2021
Net transactions value
-$268,480
Form type
4
Filing time
13 Sep 2021, 17:50:38 UTC
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUS Class A Common Stock Options Exercise $490,080 +16,000 +89% $30.63 33,942 13 Sep 2021 Direct
transaction NUS Class A Common Stock Sale $758,560 -16,000 -47% $47.41 17,942 13 Sep 2021 Direct F1, F2
holding NUS Class A Common Stock 78,068 13 Sep 2021 Held in irrevocable family trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -16,000 -18% $0.000000 74,600 13 Sep 2021 Class A Common Stock 16,000 $30.63 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale pursuant to a Rule 10b5-1 plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.15 to $47.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F3 This report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purpose of Section 16 or for any other purpose.
F4 Currently exercisable in full.